Published in Sci Rep on January 16, 2017
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 13.16
Role of YAP/TAZ in mechanotransduction. Nature (2011) 11.56
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature (2011) 7.90
The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci (1984) 4.52
Substrate modulus directs neural stem cell behavior. Biophys J (2008) 3.81
Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater (2008) 3.24
Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization. Neuroscience (1983) 3.09
Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat Mater (2013) 2.84
Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics (2010) 2.55
The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol (2007) 2.54
Optically monitoring voltage in neurons by photo-induced electron transfer through molecular wires. Proc Natl Acad Sci U S A (2012) 2.35
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell (2013) 2.33
Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep (2012) 2.31
Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J Neurosci (2001) 1.99
Embryonic stem cells as a source of models for drug discovery. Nat Rev Drug Discov (2007) 1.82
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med (2010) 1.78
Transcriptional control of midbrain dopaminergic neuron development. Development (2006) 1.74
Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells (2010) 1.74
Materials as stem cell regulators. Nat Mater (2014) 1.53
Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease. Cell Stem Cell (2014) 1.52
Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc (2011) 1.46
A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc Natl Acad Sci U S A (2013) 1.38
The role of Pax6 in forebrain development. Dev Neurobiol (2011) 1.32
Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods (2010) 1.31
Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells (2013) 1.31
How to make a midbrain dopaminergic neuron. Development (2015) 1.30
Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports (2014) 1.29
Midbrain dopamine neuron differentiation: factors and fates. Dev Biol (2007) 1.29
Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol (2012) 1.24
Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog (2009) 1.21
Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc (2011) 1.21
Soft microenvironments promote the early neurogenic differentiation but not self-renewal of human pluripotent stem cells. Integr Biol (Camb) (2012) 1.20
Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model. Nat Biotechnol (2015) 1.20
Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum Gene Ther (2011) 1.15
Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res (2012) 1.14
Physiological characterisation of human iPS-derived dopaminergic neurons. PLoS One (2014) 1.12
Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res (2011) 1.08
High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors. J Biol Chem (2010) 0.98
Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. Dev Biol (2013) 0.96
Specification of dopaminergic subsets involves interplay of En1 and Pitx3. Development (2013) 0.96
Improved PeT molecules for optically sensing voltage in neurons. J Am Chem Soc (2015) 0.93
A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing. J Am Chem Soc (2015) 0.90
Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation. Cell Rep (2015) 0.89
Transcription factors FOXA1 and FOXA2 maintain dopaminergic neuronal properties and control feeding behavior in adult mice. Proc Natl Acad Sci U S A (2015) 0.87
Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation. Cytotherapy (2013) 0.86
Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors. Proc Natl Acad Sci U S A (2015) 0.85
Alginate microcapsule as a 3D platform for the efficient differentiation of human embryonic stem cells to dopamine neurons. Stem Cell Res (2013) 0.85
Dopaminergic neurons for Parkinson's therapy. Nat Biotechnol (2012) 0.84
Temporal application of topography to increase the rate of neural differentiation from human pluripotent stem cells. Biomaterials (2012) 0.80